We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Orders FDA to Approve Watson’s Actos ANDA, Award Exclusivity
Court Orders FDA to Approve Watson’s Actos ANDA, Award Exclusivity
November 6, 2012
A district court has ordered the FDA to immediately approve Watson’s ANDA for a generic of Takeda’s billion-dollar diabetes treatment Actos.